Open Access Open Access  Restricted Access Subscription or Fee Access

Formulation Development and Evaluation of Furosemide Loaded Solid Lipid Microparticles

Velenti Chauhan, Bhavesh Akbari, Sandip Tarpara, Rohan Barse

Abstract


Furosemide is a loop diuretic because of having very low half-life, low oral bioavailability, degraded in gastric juice; it was chosen to formulate as the solid lipid microparticle (SLMs) to overcome above. In this study, an attempt was made to improve the oral bioavailability of furosemide by preparing SLMs using stearic acid (SA) and cetostearyl alcohol (CsA) as lipid polymers by hot homogenization method at different drug: polymer ratios (1:5, 1:10, 1:15 and 1:20) and Span-80 used as a emulsifier. The particle size of SLMs was found in the range of 20 to 200 μm. DSC and XRD study confirmed that drug was completely dispersed in the lipid matrix due to reduced the crystallinity of drug. The SEM of SLMs indicated that SA SLMs were found to be porous and perfectly spherical compared to CsA SLMs. IN vitro dissolution studies showed that, the release was prolonged up to 24 h from SLMs prepared with both lipids. As the speed of homogenizer and concentration of emulsifier increases, it leads to decrease in the particle size and % Encapsulation Efficiency (% EE) of SLMs. Furosemide-CsA SLMs imparted the strongest drug release retardation compared to furosemide-SA SLMs. Final formulation (capsule) showed sustained drug release throughout 24 h, compared to the marketed formulation (LASIX®-40 mg). The release pattern of formulation was found to follow first order with exhibited non-fickian diffusion-controlled release.

 

Keywords: Furosemide, cetostearyl alcohol, stearic acid, solid lipid microparticles (SLMs), oral controlled drug delivery systems

Cite this Article

Velenti Chauhan, Bhavesh Akbari, Sandip Tarpara, Rohan Barse. Formulation Development and Evaluation of Furosemide Loaded Solid Lipid Microparticles. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2019; 6(2): 6–18p.


Keywords


Furosemide, cetostearyl alcohol, stearic acid, solid lipid microparticles (SLMs), oral controlled drug delivery systems

Full Text:

PDF

References


N. Pawar, A. Merekar, S. Rawat, Y. Sharma, P. B. Patil, S. Karande, Sustained release drug delivery system: an overview, Int J Universe Pharm Life Sci 3(6) (2013) 66-81.

A. Dalpiaz, M. Mezzena, A. Scatturin, S. Scalia, Solid lipid microparticles for the stability enhancement of the polar drug N6-cyclopentyladenosine, Int J Pharm 355 (2008) 81-86.

K. D. Tripathi, Essential of Medical Pharmacology, 6th Edn, Jaypee brother medical publishers (p) ltd, (2008) 540-542.

Drug Bank: Open data drug and Drug target database, http://www.drugbank.ca/drugs/DB00695

F. Andreasen, H. E. Botker, K. Lorentzen, In vitro studies on the hydrolysis of frusemide in gastrointestinal juices, J Clin Pharmacol 14 (1982) 306-309.

A. J. Humberstone, W. N. Charman, Lipid-based vehicles for the oral delivery of poorly water soluble drugs, Adv Drug Delivery Rev 25 (1997) 103-128.

V. Sanna, N. Krischvink, P. Gustin, E. Gavini, I. Roland, L. Delattre, B. Evrard, Preparation and In Vivo Toxicity Study of Solid Lipid Microparticles as Carrier for Pulmonary Administration, AAPS Pharm Sci Tech 5(2) (2003) 1-7.

C. Long, L. Zhang, Y. Qian, Preparation and Crystal Modification of Ibuprofen- Loaded Solid Lipid Microparticles, Chinese J Chem Eng 14(4) (2006) 518-525.

H. Ali, S. Singh, Preparation and characterization of solid lipid nanoparticles of furosemide using quality by design, Particul sci Technol 6 (2018) 695-709.

Indian Pharmacopoeia, vol. – II, 6th Edn, The indian pharmacopoeia commission, Ghaziabad, (2010) pp 1391-1394.

Florey K, Analytical profile of drug substance, vol. 18, Acadamic press, New York, (1994) pp 153-193

M. Stuchlík, Z. Stanislav, Lipid-based vehicle for oral drug delivery. Biomed Papers 142 (2001) 17–26.

P. Prombutara, Y. Kulwatthanasal, N. Supaka, I. Sramala, S. Chareonpornwattana, Production of nisin-loaded solid lipid nanoparticles for sustained antimicrobial activity, Food Control 24 (2012) 184-190.

S. Jaspart, P. Bertholet, G. Piel, J. M. Dogne, L. Delattre, B. Evrard, Solid lipid microparticles as a sustained release system for pulmonary drug delivery, Eur J Pharm Biopharm 65 (2007) 47–56.

S. S. Chalikwar, V. S. Belgamwar, V. R. Talele, S. J. Surana, M. U. Patil, Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system, Colloids Surf B Biointerfaces 97 (2012) 109-116.

A. C. Silva, E. Gonzalez-Mira, M. L. García, M. A. Egea, Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): High pressure homogenization versus ultrasound, Colloids Surf B Biointerfaces 86 (2011) 158–165.

V. Venkateswarlu, K. Manjunath, Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles, J Controll Relaese 95 (2004) 627-638.

V. V. Venishetty, R. Chede, R. Komuravelli, L Adepu, R. Sistla, Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: A novel strategy to avoid intraduodenal administration, Colloids Surf B Biointerfaces 95 (2012) 1-9.

E. A. Kenneth, A. Herbest, L. Lachman, The theory and practice of industrial Pharmacy, 3rd edition, (1987), pp 131-246.

United State Pharmacopoeia, 28(2) (2006) 3018.

Indian Pharmacopoeia, vol. – I, 6th Edn, The Indian pharmacopoeia commission, Ghaziabad, 2010, pp 195-198.

B. Z. Maryam, P. Akram, Effect of Surfactant Concentration on the Particle Size, Stability and Potential Zeta of Beta carotene Nano Lipid Carrier, Int J Curr Microbiol App Sci 4(9) (2015) 924-932.

S. Kheradmandnia, E. V. Farahani, M. Nosrati, F. Atyabi, Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax, Nano Med 6 (2010) 753-759.

P. R. Ravi, N. Aditya, H. Kathuria, S. Malekar, R. Vats, Lipid nanoparticles for oral delivery of raloxifene: Optimization, stability, in vivo evaluation and uptake mechanism, Eur J Pharm Biopharm 87 (2014) 114-124.

V. G. Punitha, M. Vignesh, Formulation of niosomal suspension with enhanced oral bioavailability of diclofenac sodium, J Global Trends Pharm Sci 3(2) (2012) 656-671.

H. Vaghasiya, A. Kumar, K. Sawant, Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride, Eur J Pharm Biopharm 49 (2013) 311–322.

R. K. Subedi, K. W. Kang, H. K. Choi, Preparation and characterization of solid lipid nanoparticles loaded with doxorubicine, Eur J Pharm Sci 37 (2009) 508-518.

C. R. Raymond, J. S. Paul, C. O. Sian, Handbook of Pharmaceutical Excipients, 5th edition, Pharmaceutical Press, (2006) pp 150.

C. R. Raymond, J. S. Paul, C. O. Sian, Handbook of Pharmaceutical Excipients, 5th edition, Pharmaceutical Press, (2006) pp 737.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Research & Reviews: A Journal of Drug Formulation, Development and Production